Dexrabeprazole sodium compound and pharmaceutical composition thereof
AssigneesJiangsu Aosaikang Pharmaceutical Co., Ltd., Nanjing Hairun Pharmaceutical Co., Ltd.
InventorsXiangfeng Chen, Hongyu Chen, Xiaoxin Li, Xun Pan, Min Sun
Life of this patent
Estimating the term…
Abstract
A dexrabeprazole sodium compound includes crystal forms B and C. The crystal form B has good stability and flowability. The crystal form C is an anhydrous crystal form and has good stability and low hygroscopicity. The crystal forms are suitable for preparing a dexrabeprazole sodium preparation.
Claims4
A dexrabeprazole sodium compound of Formula (I), wherein the dexrabeprazole sodium compound is crystal form C, which has an XRPD pattern represented by angle 2θ with characteristic peaks at 6.22±0.2°, 12.14±0.2°, 12.46±0.2°, 15.82±0.2°, 18.90±0.2°, 22.38±0.2°, 26.56±0.2°, and 28.06±0.2° when measured by Cu target radiation having a DSC pattern with an exothermic peak at about 234° C.±5° C.
Dependencies are inferred from the claim text.